Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4555 |  AEON AEON Biopharma, Inc. Class A Common Stock | 0.31 USD | 0.00% | +3.33% | +3.33% | -70.19% | 15.46 M USD | ||
| 4559 |  ICU SeaStar Medical Holding Corporation - Common Stock | 3.49 USD | -6.18% | -7.67% | +12.94% | +41.87% | 15.38 M USD | ||
| 4568 |  NCEL NewcelX Ltd. - Ordinary Shares | 3.11 USD | +2.30% | +9.89% | -5.47% | -38.78% | 14.92 M USD | ||
| 4571 |  KTTA Pasithea Therapeutics Corp. - Common Stock | 0.44 USD | 0.00% | -6.38% | -22.81% | -43.59% | 14.70 M USD | ||
| 4573 |  TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 USD | -17.86% | -30.30% | -28.13% | -89.55% | 14.61 M USD | ||
| 4576 |  TVRD Tvardi Therapeutics, Inc. - Common Stock | 1.08 USD | -1.82% | -13.60% | -40.98% | -70.00% | 14.41 M USD | ||
| 4577 |  KZIA Kazia Therapeutics Limited - American Depositary Shares | 8.82 USD | -5.06% | -8.03% | -24.94% | +50.77% | 14.28 M USD | ||
| 4579 |  HIND Vyome Holdings, Inc. - Common Stock | 2.03 USD | -0.49% | +10.33% | -3.33% | -63.81% | 14.25 M USD | ||
| 4588 |  KPTI Karyopharm Therapeutics Inc. - Common Stock | 0.60 USD | -7.69% | -30.23% | -64.29% | -93.78% | 13.61 M USD | ||
| 4589 |  INAB IN8bio, Inc. - Common Stock | 1.38 USD | -1.43% | -2.82% | +27.78% | -17.37% | 13.60 M USD | ||
| 4590 |  RADX Radiopharm Theranostics Limited American Depositary Shares | 1.15 USD | -2.54% | -20.14% | -45.50% | -84.38% | 13.59 M USD | ||
| 4592 |  CTXR Citius Pharmaceuticals, Inc. - Common Stock | 0.49 USD | -2.00% | -9.26% | -18.33% | -62.60% | 13.45 M USD | ||
| 4596 |  CLRB Cellectar Biosciences, Inc. - Common Stock | 1.40 USD | -7.28% | -28.21% | -40.43% | -55.41% | 13.23 M USD | ||
| 4620 |  PLUR Pluri Inc. - Common Stock | 1.00 USD | -3.85% | -3.85% | -25.37% | -73.82% | 12.34 M USD | ||
| 4626 |  INTS Intensity Therapeutics, Inc. - Common Stock | 3.68 USD | -3.16% | +12.54% | -8.91% | +894.59% | 12.01 M USD | ||
| 4627 |  PASG Passage Bio, Inc. - Common Stock | 3.73 USD | -3.37% | -12.85% | -25.25% | -57.81% | 12.00 M USD | ||
| 4631 |  DARE Dare Bioscience, Inc. - Common Stock | 0.77 USD | -2.53% | -11.49% | +10.00% | -53.33% | 11.77 M USD | ||
| 4635 |  ASBP Aspire Biopharma Holdings, Inc. - Common Stock | 8.30 USD | -3.82% | -0.84% | +1.10% | +432.05% | 11.64 M USD | ||
| 4641 |  PHIO Phio Pharmaceuticals Corp. - Common Stock | 0.99 USD | -1.00% | -1.98% | -3.88% | -16.81% | 11.50 M USD | ||
| 4645 |  TPST Tempest Therapeutics, Inc. - Common Stock | 0.77 USD | -2.53% | -6.10% | -18.09% | -67.78% | 11.40 M USD |
Notizie Biotechnology Stocks
Il farmaco di Pharvaris per l’HAE mostra un sollievo più rapido
Raymond James avvia la copertura di Kymera Therapeutics con rating outperform
Raymond James avvia la copertura di Nektar con rating Market Perform
Palisade Bio: Raymond James avvia copertura con rating Outperform
Raymond James conferma il rating su Liquidia tra i ricorsi legali
Tenax Therapeutics sospende temporaneamente l’arruolamento nello studio LEVEL-2 di TNX-103 per modificare i criteri; richiede un incontro con la FDA
Ginkgo Bioworks supporterà NSF X-Labs con accesso al laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |